UniProtKB/Swiss-Prot Q9NSE4 : Variant p.Pro909Leu
Isoleucine--tRNA ligase, mitochondrial
Gene: IARS2
Feedback ?
Variant information
Variant position:
909
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
US
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Proline (P) to Leucine (L) at position 909 (P909L, p.Pro909Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In CAGSSS; uncertain significance.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
909
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
1012
The length of the canonical sequence.
Location on the sequence:
FLGSIPGKNAAEYKVITVIE
P GLLFEIIEMLQSEETSSTSQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human FLGSIPGKNAAEYKVITVIEP GLLFEIIEMLQSEETSSTSQ
Mouse FLGSIPGKNAAEYEVIIVIEP GLLFEIMEMLQAEETSSTSQ
Chicken FLGSISGKNALEYEVIIVIEP GLLFELMEALQAEESSRVSQ
Slime mold VLQSMRSQGIIGRSDETIMEL TVTNEESSPFYDNLFAINSQ
Baker's yeast FQEEFKRLSLEEGVTKTTHSH VTIFTKHHLPFS-----SDE
Fission yeast LLITAARENLT--IKNSLEAY VVIKSKSQSLLSFLKNYSSD
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
49 – 1012
Isoleucine--tRNA ligase, mitochondrial
Literature citations
Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome.
Schwartzentruber J.; Buhas D.; Majewski J.; Sasarman F.; Papillon-Cavanagh S.; Thiffaut I.; Sheldon K.M.; Massicotte C.; Patry L.; Simon M.; Zare A.S.; McKernan K.J.; Michaud J.; Boles R.G.; Deal C.L.; Desilets V.; Shoubridge E.A.; Samuels M.E.;
Hum. Mutat. 35:1285-1289(2014)
Cited for: INVOLVEMENT IN CAGSSS; VARIANT CAGSSS LEU-909; VARIANT LYS-708;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.